These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11065350)

  • 21. Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a helper-dependent adenoviral vector.
    Lena AM; Giannetti P; Sporeno E; Ciliberto G; Savino R
    J Gene Med; 2005 Aug; 7(8):1086-96. PubMed ID: 15772935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
    Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
    Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model.
    Johnston J; Tazelaar J; Rivera VM; Clackson T; Gao GP; Wilson JM
    Mol Ther; 2003 Apr; 7(4):493-7. PubMed ID: 12727112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.
    Copland IB; Jolicoeur EM; Gillis MA; Cuerquis J; Eliopoulos N; Annabi B; Calderone A; Tanguay JF; Ducharme A; Galipeau J
    Cardiovasc Res; 2008 Aug; 79(3):405-15. PubMed ID: 18397963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospects for correction of thalassemia by genetic engineering.
    Gale RP
    Prog Clin Biol Res; 1989; 309():141-59. PubMed ID: 2571166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.
    Eliopoulos N; Al-Khaldi A; Crosato M; Lachapelle K; Galipeau J
    Gene Ther; 2003 Mar; 10(6):478-89. PubMed ID: 12621452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates.
    Fattori E; Cappelletti M; Zampaglione I; Mennuni C; Calvaruso F; Arcuri M; Rizzuto G; Costa P; Perretta G; Ciliberto G; La Monica N
    J Gene Med; 2005 Feb; 7(2):228-36. PubMed ID: 15515133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin-targeted gene transfer using in vivo electroporation.
    Maruyama H; Ataka K; Higuchi N; Sakamoto F; Gejyo F; Miyazaki J
    Gene Ther; 2001 Dec; 8(23):1808-12. PubMed ID: 11803401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T; Tubb J; Emery DW
    Blood Cells Mol Dis; 2006; 37(1):1-7. PubMed ID: 16814578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
    Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
    J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on gene therapy for hemoglobin disorders.
    Persons DA
    Curr Opin Mol Ther; 2003 Oct; 5(5):508-16. PubMed ID: 14601520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
    Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY
    Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of globin gene therapy for the treatment of beta-thalassaemia.
    Lisowski L; Sadelain M
    Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
    Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
    Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors.
    Shao G; Greathouse K; Huang Q; Wang CM; Sferra TJ
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):168-79. PubMed ID: 16877980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adeno-associated virus mediated expression of human erythropoietin in vitro.
    Diao Y; Xu RA; Wang GJ; Zhao XC
    Acta Pharmacol Sin; 2002 Jan; 23(1):55-8. PubMed ID: 11860738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum erythropoietin levels in pediatric patients with beta-thalassemia/hemoglobin E.
    Paritpokee N; Wiwanitkit V; Bhokaisawan N; Boonchalermvichian C; Preechakas P
    Clin Lab; 2002; 48(11-12):631-4. PubMed ID: 12465748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-level expression of naked DNA delivered to rat liver via tail vein injection.
    Maruyama H; Higuchi N; Nishikawa Y; Kameda S; Iino N; Kazama JJ; Takahashi N; Sugawa M; Hanawa H; Tada N; Miyazaki J; Gejyo F
    J Gene Med; 2002; 4(3):333-41. PubMed ID: 12112650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.